ArticleMedicine2026
The association of smoking and opium consumption with the risk and prognosis of colorectal cancer: A multicenter retrospective cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is among the leading global causes of cancer-related morbidity and mortality. While lifestyle factors such as smoking and opium use have been implicated in CRC risk and prognosis, their clinicopathological and survival associations remain unclear. This study aimed to evaluate the impact of these exposures on CRC development, tumor characteristics, and overall survival (OS). A retrospective cohort study with a total of 270 participants aged ≥45 years from 2019 to 2020 was conducted in a multicenter design. Participants were divided into 2 groups of patients with CRC who underwent elective surgery and patients who were admitted for noncancerous conditions. Exposures to smoking and opium, clinicopathological profiles, laboratory data, and survival outcomes over a 5-year follow-up were extracted retrospectively via medical records. Adjusted and unadjusted odds ratios (OR) were computed to identify predictors of CRC development using binary logistic regression analysis. Kaplan-Meier and multivariable Cox regression analyses assessed survival differences and hazard ratios by clinicopathological characteristics. Smoking was more prevalent among CRC patients than controls (P = .041) and was associated with higher CRC risk in univariate logistic regression (OR = 2.19, 95% confidence interval 1.01-4.72; P = .045), though this association was not significant after adjustment (OR = 2.26, 95% confidence interval 0.96-5.27; P = .059). Opium consumption showed no significant association with CRC risk (P = .374), except for a lower platelet count among users (P = .023). In multivariate analysis using Cox regression, neither smoking nor opium use was significantly associated with OS. Kaplan-Meier curves confirmed no survival differences between exposed and unexposed groups. Smoking showed a potential role in CRC development, while opium consumption was not linked to prognosis. These findings highlight lifestyle exposures as possible contributors to CRC risk, warranting further investigation in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.